Home
Jagsonpal Pharmaceuticals Ltd PE Ratio

Jagsonpal Pharmaceuticals Ltd
NSE: JAGSNPHARM
PE
Key Highlights
- The P/E Ratio of Jagsonpal Pharmaceuticals Ltd is 40 as of 22 Feb 12:16 PM .
- The P/E Ratio of Jagsonpal Pharmaceuticals Ltd changed from 5.8 on March 2020 to 32.9 on March 2024 . This represents a CAGR of 41.50% over 5 years.
- The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 219.45 as of 21 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Jagsonpal Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Jagsonpal Pharmaceuticals Ltd
Company Fundamentals for Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Ltd
NSE: JAGSNPHARM
Share Price
Market Price of Jagsonpal Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 219.45 |
20 Feb 2025 | 218.7 |
19 Feb 2025 | 214.15 |
18 Feb 2025 | 215.8 |
17 Feb 2025 | 220.85 |
14 Feb 2025 | 229.95 |
13 Feb 2025 | 229.25 |
12 Feb 2025 | 241.05 |
11 Feb 2025 | 220.3 |
10 Feb 2025 | 241.8 |
SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd
BlinkX Score for Jagsonpal Pharmaceuticals Ltd
Asset Value vs Market Value of Jagsonpal Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Jagsonpal Pharmaceuticals Ltd | 1456 | 39.97 |
Sun Pharmaceuticals Industries Ltd | 394223 | 33.4 |
Divis Laboratories Ltd | 152610 | 73.8 |
Cipla Ltd | 119067 | 23.9 |
Torrent Pharmaceuticals Ltd | 102739 | 55.2 |
Dr Reddys Laboratories Ltd | 96124 | 17.9 |
Company | |
---|---|
Jagsonpal Pharmaceuticals Ltd | 1456 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
PE Ratio of Jagsonpal Pharmaceuticals Ltd Explained
₹1456
Market cap
₹52
Earnings
40.0X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Jagsonpal Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Jagsonpal Pharmaceuticals Ltd
Historical Revenue, EBITDA and Net Profit of Jagsonpal Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Jagsonpal Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Jagsonpal Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Jagsonpal Pharmaceuticals Ltd
About Jagsonpal Pharmaceuticals Ltd
- Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
- The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
- Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
- It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
- In 1994, the company has also promoted Aresco Financial Services, a new financial company.
Jagsonpal Pharmaceuticals Ltd News Hub
Jagsonpal Pharmaceuticals AGM scheduled
Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting (AGM) of the company will b
Read more
13 Aug 24
Jagsonpal Pharmaceuticals standalone net profit declines 28.74% in the June 2024 quarter
Net profit of Jagsonpal Pharmaceuticals declined 28.74% to Rs 5.33 crore in the quarter ended June 2
Read more
08 Aug 24
Jagsonpal Pharmaceuticals declare Quarterly Result
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 August 2
Read more
01 Aug 24
Jagsonpal Pharmaceuticals to table results
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 October
Read more
17 Oct 24